Jump to content
  • Sign Up

Archived

This topic is now archived and is closed to further replies.

Scott Adams

Biolinerx's Bl-7010, For The Treatment Of Celiac, To Be Presented At Two ... - Fort Mills Times

Recommended Posts

BioLineRx's BL-7010, for the Treatment of Celiac, to be Presented at Two ...

Fort Mills Times

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that the Company was invited to deliver an oral presentation at the 2013 National Education Conference & Gluten-Free Expo, the Celiac Disease ...

View the full article

Share this post


Link to post
Share on other sites

×
×
  • Create New...